NS
Niyati Sutaria James
About Niyati Sutaria James
Data last updated:
Niyati Sutaria James is a Director at Hematology Cancer Consortium - Association (since 2021). The company operates in Healthcare. Hematology Cancer Consortium - Association reported revenue of ₹1.40 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hematology Cancer Consortium - Association U85100MH2020NPL335745 | Director | 08 Dec 2021 | 2020 | ₹1.40 Cr (FY 2024) | Active |
Board colleagues of Niyati Sutaria James
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavisha Sudarshan Sanadhya | 07753222 | Hematology Cancer Consortium - Association | Ceo |
| Bhavisha Sudarshan Sanadhya | Hematology Cancer Consortium - Association | Ceo | |
| Palani Thyagarajan | 09428178 | Hematology Cancer Consortium - Association | Director |
| Vikram | 08663317 | Hematology Cancer Consortium - Association | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Niyati Sutaria James
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niyati Sutaria James
Niyati Sutaria James currently holds 1 directorship: Hematology Cancer Consortium - Association (Director, since 08 Dec 2021, revenue ₹1.40 Cr (FY 2024)).
Niyati Sutaria James was first appointed on 08 Dec 2021 as Director at Hematology Cancer Consortium - Association.
The current boards of Niyati Sutaria James's companies include Bhavisha Sudarshan Sanadhya (Hematology Cancer Consortium - Association), Bhavisha Sudarshan Sanadhya (Hematology Cancer Consortium - Association), Palani Thyagarajan (Hematology Cancer Consortium - Association), Vikram (Hematology Cancer Consortium - Association).